JPX · 4891.T
TMS Co., Ltd.
¥135-¥1 (-0.74%)
TMS Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.18% below the high.
Loading market information…
JPX · 2796.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
Pharmarise Holdings Corporation’s quoted price sits in the lower half of its reported 52-week range, 9.57% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Pharmarise Holdings Corporation’s forward annual dividend is ¥14 per share, paid annual. The forward yield is 2.79% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Pharmarise Holdings Corporation’s next earnings report is currently expected on Dec 17, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Pharmarise Holdings Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Pharmarise Holdings Corporation predominantly oversees a chain of pharmacies that dispense prescription medications throughout Japan. These establishments fulfill prescriptions provided by medical facilities, offering vital pharmaceutical services to patients. Beyond its primary dispensing activities, the company also manages drugstores and convenience stores, and retails cosmetic products. Additionally, it provides services including the safekeeping and administration of patient medical records for healthcare institutions, operates medical complex centers, and offers temporary staffing assistance. As of May 31, 2021, the corporation maintained a network of 347 outlets. Pharmarise Holdings Corporation was founded in 1984 and its main office is located in Tokyo, Japan.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:04 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥135-¥1 (-0.74%)
TMS Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.18% below the high.
¥2,550-¥11 (-0.43%)
WDB coco Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 9.73% below the high.
¥845+¥1 (+0.12%)
Shigematsu Works Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 37.27% below the high.
¥202-¥2 (-0.98%)
Precision System Science Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.44% below the high.
¥1,515¥0 (0.0%)
Nippon Chemiphar Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 18.42% below the high.
¥391-¥1 (-0.26%)
Care Twentyone Corporation’s quoted price sits in the lower half of its reported 52-week range, 19.21% below the high.
¥132+¥2 (+1.54%)
PRISM BioLab Co.,LTD’s quoted price sits in the lower half of its reported 52-week range, 52.69% below the high.
¥49-¥1 (-2.0%)
Chordia Therapeutics Inc.’s quoted price sits in the lower half of its reported 52-week range, 72.63% below the high.
